Syndax Pharmaceuticals
SNDX
SNDX
215 hedge funds and large institutions have $1.3B invested in Syndax Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 89 increasing their positions, 60 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 210 → 215 (+5)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
24% less capital invested
Capital invested by funds: $1.71B → $1.3B (-$418M)
Holders
215
Holding in Top 10
8
Calls
$19.4M
Puts
$6.29M
Top Buyers
| 1 | +$58.5M | |
| 2 | +$57.4M | |
| 3 | +$35.4M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$21.1M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$18.5M |
Top Sellers
| 1 | -$49.7M | |
| 2 | -$37.1M | |
| 3 | -$21.3M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$18M |
| 5 |
CC
Commodore Capital
New York
|
-$17M |